Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number PB2013-101510
Title Review of Medicare Outpatient Billing for Selected Drugs at Essentia Health Duluth.
Publication Date Aug 2012
Media Count 16p
Personal Author N/A
Abstract Essentia Health Duluth (Essentia) is an acute-care hospital located in Duluth, Minnesota. Based on data analysis, we reviewed $1,261,769 in Medicare payments to Essentia for 131 line items for injections of selected drugs that Essentia billed to Medicare during our audit period (January 1, 2008, through April 30, 2011). These line items consisted of injections for baclofen, infliximab, trastuzumab, rituximab, bortezomib, immune globulin, bevacizumab, epoetin alfa, and paclitaxel. Our objective was to determine whether Essentia billed Medicare for injections of selected drugs in accordance with Federal requirements.
Keywords Audits
Billing
Essentia Health Duluth
Federal requirements
Hospitals
Incorrect billing
Injectable drugs
Medicare
Methodologies
Minnesota
Objectives
Outpatient claims
Prescription drugs
Recommendations
Scope

 
Source Agency Department of Health and Human Services, Washington, DC
NTIS Subject Category 44Q - Health Related Costs
57Q - Pharmacology & Pharmacological Chemistry
Corporate Author Department of Health and Human Services, Washington, DC. Office of the Inspector General.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1303
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader